Prodotti GS / Area COVID-19
Veklury: antiviral activity against Omicron subvariants - CHMP opinion received on 10th November
![Immagine News](/media/0icnkhat/cat-1.jpg?center=0.55476190476190479,0.25&mode=crop&width=722&height=442)
Today (10 November 2022)CHMP has issued a positive opinion for the EU Veklury Type II variation (EMEA/H/C/005622/II/0042) on the antiviral activity of remdesivir against the Omicron subvariants BA.2.12.1, BA.4 and BA.5.
Consequential to this, the section 5.1 of SmPC is updated to reflect the newly generated in vitro data on subvariant susceptibility accordingly.
Grazie per il tuo feedback!